BMRN vs DOCN · P/E 40, rev $2.85B vs P/E 75, rev $204.9M
Biomarin Pharmaceutical Inc (BMRN) versus DigitalOcean Holdings Inc (DOCN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
DigitalOcean Holdings Inc (DOCN) is a software - infrastructure company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported DOCN revenue for 2024-12-31 was $204.9M. Net income was $18.3M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. DOCN currently screens at market cap $17.73B and trailing P/E 74.5.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. DOCN currently screens at market cap $17.73B and trailing P/E 74.5.
Not investment advice. Open the BMRN and DOCN stock pages for the full models.
Not investment advice.